Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC challenge study of dopamine response and psychotic effects in schizophrenia and healthy adults
NL-OMON27472Active, not recruiting
- Sponsor
- Maastricht University
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dronabinol (2 arms), sponsored by Maastricht University. Primary endpoints: Dopamine response after THC and placebo and Psychotic experiences in response to THC and placebo. Started May 2009; status: active, not recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NL-OMON27472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27472.